DN-RANKL

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameDN-RANKL
Drug Alias NameRANKL inhibitor (Xencor)DN-RANKL
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTumor necrosis factor ligand superfamily member 11 inhibitors
TargetsTumor necrosis factor ligand superfamily member 11
Therapy Area/IndicationsOsteoporosisNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesXencor Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesXencor Inc
Active IndicationsN/A
Inactive IndicationsOsteoporosisNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A